Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT02132689
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT02132689
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Czechia
- Registry status
- Completed
Technical summary
Registry record NCT02132689. Non-randomized; no masking; primary purpose treatment. Start 2011-03 (actual); primary completion 2015-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism
- Acronym
- CONTACT-SPE
- Condition
- Pulmonary Embolism
- Intervention (Drug)
- Actilyse (Thrombolytic therapy)
- Intervention (Drug)
- Heparine (Standard anticoagulation therapy)
- Lead sponsor
- University Hospital Ostrava
- Collaborator
- Municipal Hospital Ostrava Fifejdy
- Collaborator
- Silesian Hospital Opava
Record details
- Record id
cardio:ct-nct02132689- Content hash
64662212dcf627377900749b96122cd86daf45257000f83a485d3d243afe6599